{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T04:58:20Z","timestamp":1794977900129,"version":"4.9.1"},"reference-count":70,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is common chronic metabolic liver disorder which is associated with fat accumulation in the liver. It causes a wide range of pathological effects such as insulin resistance, obesity, hypertension, diabetes, non-alcoholic steatohepatitis (NASH) and cirrhosis, cardiovascular diseases. The molecular mechanisms that cause the initiation and progression of NAFLD remain fully unclear. Inflammation is regarded as a significant mechanism which could result in cell death and tissue injury. Accumulation of leukocytes and hepatic inflammation are important contributors in NAFLD. Excessive inflammatory response can deteriorate the tissue injury in NAFLD. Thus, inhibition of inflammation improves NAFLD by reducing intrahepatic fat content, increasing \u03b2-oxidation of fatty acids, inducing hepato-protective autophagy, overexpressing peroxisome proliferator-activated receptor- \u03b3 (PPAR-\u03b3), as well as attenuating hepatocyte apoptosis and increasing insulin sensitivity. Therefore, understanding the molecules and signaling pathways suggests us valuable information about NAFLD progression. This review aimed to evaluate the inflammation in NAFLD and the molecular mechanism on NAFLD.<\/jats:p>","DOI":"10.3389\/fphar.2023.1081334","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T02:59:37Z","timestamp":1678935577000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["Recent evaluation about inflammatory mechanisms in nonalcoholic fatty liver disease"],"prefix":"10.3389","volume":"14","author":[{"given":"Chong","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongpan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41575-020-00406-0","article-title":"Nonalcoholic fatty liver disease: Another leap forward","volume":"18","author":"Abdelmalek","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1177\/0003319714557353","article-title":"Nonalcoholic fatty liver disease, cardiovascular risk, and carotid inflammation","volume":"66","author":"Al-Rasadi","year":"2015","journal-title":"Angiology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"767314","DOI":"10.3389\/fendo.2021.767314","article-title":"Targeting inflammation in NASH","volume":"12","author":"Albhaisi","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/metabo13010101","article-title":"Metabolic role of autophagy in the pathogenesis and development of NAFLD","volume":"13","author":"An","year":"2023","journal-title":"Metabolites"},{"key":"B5","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/clpt.2010.2","article-title":"Nuclear receptors, inflammation, and liver disease: Insights for cholestatic and fatty liver diseases [J]","volume":"87","author":"Arrese","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1007\/s10620-016-4049-x","article-title":"Innate immunity and inflammation in NAFLD\/NASH","volume":"61","author":"Arrese","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1530\/JOE-13-0201","article-title":"Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance","volume":"218","author":"Asrih","year":"2013","journal-title":"J. Endocrinol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1007\/s10753-017-0628-z","article-title":"NLRP3 deletion inhibits the non-alcoholic steatohepatitis development and inflammation in kupffer cells induced by palmitic acid","volume":"40","author":"Cai","year":"2017","journal-title":"Inflammation"},{"key":"B9","doi-asserted-by":"publisher","first-page":"4241","DOI":"10.3390\/ijms22084241","article-title":"Metabolic dysfunction-associated fatty liver disease (MAFLD)-A condition associated with heightened sympathetic activation","volume":"22","author":"Carnagarin","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.3390\/antiox11071284","article-title":"Genetic factors associated with response to vitamin E treatment in NAFLD","volume":"11","author":"Civelek","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","article-title":"Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters","volume":"49","author":"Cobbina","year":"2017","journal-title":"Drug Metab. Rev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/nu11010194","article-title":"Spirulina liquid extract protects against fibrosis related to non-alcoholic steatohepatitis and increases ursodeoxycholic acid","volume":"11","author":"Cou\u00e9","year":"2019","journal-title":"Nutrients"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.3389\/fimmu.2020.01582","article-title":"The effects of type 2 diabetes mellitus on organ metabolism and the immune system","volume":"11","author":"Daryabor","year":"2020","journal-title":"Front. Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2042018820969025","DOI":"10.1177\/2042018820969025","article-title":"The relation between serum adipose differentiation-related protein and non-alcoholic fatty liver disease in type 2 diabetes mellitus","volume":"11","author":"Fan","year":"2020","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"B15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/978-981-10-8684-7_3","article-title":"Pathogenesis of NASH: How metabolic complications of overnutrition favour lipotoxicity and pro-inflammatory fatty liver disease","volume":"1061","author":"Farrell","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.2147\/DDDT.S357530","article-title":"Comprehensive analysis of metabolic changes in male mice exposed to sodium valproate based on GC-MS analysis","volume":"16","author":"Gao","year":"2022","journal-title":"Drug Des. Devel Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"10062","DOI":"10.3390\/ijms221810062","article-title":"Methyl brevifolincarboxylate attenuates free fatty acid-induced lipid metabolism and inflammation in hepatocytes through AMPK\/NF-\u03baB signaling pathway","volume":"22","author":"Geethangili","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"15489","DOI":"10.3390\/ijms232415489","article-title":"Non-alcoholic fatty liver disease (NAFLD) pathogenesis and natural products for prevention and treatment","volume":"23","author":"Guo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/cells12010022","article-title":"Current therapeutic options and potential of mesenchymal stem cell therapy for alcoholic liver disease","volume":"12","author":"Han","year":"2022","journal-title":"Cells"},{"key":"B20","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev-pathol-012615-044224","article-title":"Nonalcoholic fatty liver disease: Pathogenesis and disease spectrum","volume":"11","author":"Hardy","year":"2016","journal-title":"Annu. Rev. Pathol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/hep4.1801","article-title":"Role of cholesterol-associated steatohepatitis in the development of NASH","volume":"6","author":"Horn","year":"2022","journal-title":"Hepatol. Commun."},{"key":"B22","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","article-title":"Immune cell-mediated features of non-alcoholic steatohepatitis","volume":"22","author":"Huby","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1194\/jlr.M072454","article-title":"Cholesterol crystallization within hepatocyte lipid droplets and its role in murine NASH","volume":"58","author":"Ioannou","year":"2017","journal-title":"J. Lipid Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.3390\/nu13113765","article-title":"Euphausia pacifica (north pacific krill): Review of chemical features and potential benefits of 8-HEPE against metabolic syndrome, dyslipidemia, NAFLD, and atherosclerosis","volume":"13","author":"Ishida","year":"2021","journal-title":"Nutrients"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.3390\/cells11091500","article-title":"Recent advancements in antifibrotic therapies for regression of liver fibrosis","volume":"11","author":"Jangra","year":"2022","journal-title":"Cells"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jhep.2018.01.019","article-title":"Fructose and sugar: A major mediator of non-alcoholic fatty liver disease","volume":"68","author":"Jensen","year":"2018","journal-title":"J. Hepatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s13238-020-00804-9","article-title":"Targeting the alternative bile acid synthetic pathway for metabolic diseases","volume":"12","author":"Jia","year":"2021","journal-title":"Protein Cell."},{"key":"B28","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3390\/biomedicines9070762","article-title":"Role of leptin in non-alcoholic fatty liver disease","volume":"9","author":"Jim\u00e9nez-Cortegana","year":"2021","journal-title":"Biomedicines"},{"key":"B29","doi-asserted-by":"publisher","first-page":"6468","DOI":"10.3390\/ijms22126468","article-title":"Atorvastatin modulates bile acid homeostasis in mice with diet-induced nonalcoholic steatohepatitis","volume":"22","author":"Lastuvkova","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrgastro.2010.41","article-title":"The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome","volume":"7","author":"Lim","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"66","DOI":"10.29219\/fnr.v66.8101","article-title":"Gardenia jasminoides J. Ellis extract GJ-4 attenuates hyperlipidemic vascular dementia in rats via regulating PPAR-\u03b3-mediated microglial polarization","volume":"66","author":"Liu","year":"2022","journal-title":"Food Nutr. Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"108751","DOI":"10.1016\/j.jnutbio.2021.108751","article-title":"Consumption of soybean or olive oil at recommended concentrations increased the intestinal microbiota diversity and insulin sensitivity and prevented fatty liver compared to the effects of coconut oil","volume":"94","author":"L\u00f3pez-Salazar","year":"2021","journal-title":"J. Nutr. Biochem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"597648","DOI":"10.3389\/fendo.2020.597648","article-title":"Chronic inflammation in non-alcoholic steatohepatitis: Molecular mechanisms and therapeutic strategies","volume":"11","author":"Luci","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"44612","DOI":"10.1038\/srep44612","article-title":"Effect of modulation of PPAR-\u03b3 activity on Kupffer cells M1\/M2 polarization in the development of non-alcoholic fatty liver disease","volume":"7","author":"Luo","year":"2017","journal-title":"Sci. Rep."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1053\/j.gastro.2016.02.066","article-title":"Pathogenesis of nonalcoholic steatohepatitis","volume":"150","author":"Machado","year":"2016","journal-title":"Gastroenterology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.cld.2017.08.007","article-title":"Pathophysiology of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"22","author":"Manne","year":"2018","journal-title":"Clin. Liver Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/hep.27395","article-title":"The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease [J]","volume":"61","author":"Maximos","year":"2015","journal-title":"Hepatology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"946474","DOI":"10.3389\/fphys.2022.946474","article-title":"Emerging role of hepatic ketogenesis in fatty liver disease","volume":"13","author":"Mooli","year":"2022","journal-title":"Front. Physiol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3390\/medicina58060761","article-title":"An update on the chemokine system in the development of NAFLD","volume":"58","author":"Nagata","year":"2022","journal-title":"Med. Kaunas."},{"key":"B40","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1002\/hep.28941","article-title":"Prevention of hepatic fibrosis with liver microsomal triglyceride transfer protein deletion in liver fatty acid binding protein null mice","volume":"65","author":"Newberry","year":"2017","journal-title":"Hepatology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"155272","DOI":"10.1016\/j.metabol.2022.155272","article-title":"CX3CL1\/CX3CR1 interaction protects against lipotoxicity-induced nonalcoholic steatohepatitis by regulating macrophage migration and M1\/M2 status","volume":"136","author":"Ni","year":"2022","journal-title":"Metabolism"},{"key":"B42","doi-asserted-by":"publisher","first-page":"10541","DOI":"10.3390\/ijms221910541","article-title":"A distinctive NAFLD signature in adipose tissue from women with severe obesity","volume":"22","author":"Osorio-Conles","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3389\/fendo.2020.00252","article-title":"Causes and consequences of hypertriglyceridemia","volume":"11","author":"Packard","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B44","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/hep4.1479","article-title":"Pathogenesis of nonalcoholic steatohepatitis: An overview","volume":"4","author":"Parthasarathy","year":"2020","journal-title":"Hepatol. Commun."},{"key":"B45","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12902-022-00980-1","article-title":"Non-alcoholic fatty liver disease (NAFLD): A review of pathophysiology, clinical management and effects of weight loss","volume":"22","author":"Pouwels","year":"2022","journal-title":"BMC Endocr. Disord."},{"key":"B46","doi-asserted-by":"publisher","first-page":"eaaz2841","DOI":"10.1126\/scitranslmed.aaz2841","article-title":"Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome","volume":"12","author":"Rom","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/hep.29094","article-title":"Liver fat accumulation as a barometer of insulin responsiveness again points to adipose tissue as the culprit","volume":"65","author":"Rotman","year":"2017","journal-title":"Hepatology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3390\/ijms20020308","article-title":"Intestinal microbiota protects against MCD diet-induced steatohepatitis","volume":"20","author":"Schneider","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","article-title":"Triggering and resolution of inflammation in NASH","volume":"15","author":"Schuster","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","article-title":"Mechanisms of fibrosis development in nonalcoholic steatohepatitis","volume":"158","author":"Schwabe","year":"2020","journal-title":"Gastroenterology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"923120","DOI":"10.3389\/fnut.2022.923120","article-title":"Effect of high-fat and low-fat dairy products on cardiometabolic risk factors and immune function in a low birthweight swine model of diet-induced insulin resistance","volume":"9","author":"She","year":"2022","journal-title":"Front. Nutr."},{"key":"B52","doi-asserted-by":"publisher","first-page":"910493","DOI":"10.3389\/fphar.2022.910493","article-title":"The effect of lithocholic acid on the gut-liver Axis","volume":"13","author":"Sheng","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"213","DOI":"10.20524\/aog.2022.0704","article-title":"Emerging advances in the pharmacologic treatment of nonalcoholic steatohepatitis and related cirrhosis","volume":"35","author":"Sinakos","year":"2022","journal-title":"Ann. Gastroenterol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"100580","DOI":"10.1016\/j.ymgmr.2020.100580","article-title":"Mtrr hypomorphic mutation alters liver morphology, metabolism and fuel storage in mice","volume":"23","author":"Sowton","year":"2020","journal-title":"Mol. Genet. Metab. Rep."},{"key":"B55","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.freeradbiomed.2019.05.029","article-title":"Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease","volume":"144","author":"Svegliati-Baroni","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3390\/diagnostics10060395","article-title":"Could SCGF-beta levels Be associated with inflammation markers and insulin resistance in male patients suffering from obesity-related NAFLD?","volume":"10","author":"Tarantino","year":"2020","journal-title":"Diagn. (Basel)"},{"key":"B57","doi-asserted-by":"publisher","first-page":"9093","DOI":"10.3390\/ijms22169093","article-title":"Palmitic acid lipotoxicity in microglia cells is ameliorated by unsaturated fatty acids","volume":"22","author":"Urso","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1039\/c7fo00090a","article-title":"Molecular adaptations underlying the beneficial effects of hydroxytyrosol in the pathogenic alterations induced by a high-fat diet in mouse liver: PPAR-\u03b1 and Nrf2 activation, and NF-\u03baB down-regulation","volume":"19","author":"Valenzuela","year":"2017","journal-title":"Food Funct."},{"key":"B59","doi-asserted-by":"publisher","first-page":"16529","DOI":"10.1038\/s41598-018-33070-1","article-title":"FXR agonist obeticholic acid induces liver growth but exacerbates biliary injury in rats with obstructive cholestasis","volume":"8","author":"van Golen","year":"2018","journal-title":"Sci. Rep."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1093\/jn\/nxaa183","article-title":"A low \u03c9-6 to \u03c9-3 PUFA ratio (n-6:n-3 PUFA) diet to treat fatty liver disease in obese youth","volume":"150","author":"Van Name","year":"2020","journal-title":"J. Nutr."},{"key":"B61","doi-asserted-by":"publisher","first-page":"923599","DOI":"10.3389\/fimmu.2022.923599","article-title":"The role of gut microbiota in some liver diseases: From an immunological perspective","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3390\/metabo12030238","article-title":"Emerging role of nuclear receptors for the treatment of NAFLD and NASH","volume":"12","author":"Welch","year":"2022","journal-title":"Metabolites"},{"key":"B63","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1002\/hep.29523","article-title":"NLRP3 inflammasome driven liver injury and fibrosis: Roles of IL-17 and TNF in mice","volume":"67","author":"Wree","year":"2018","journal-title":"Hepatology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"675535","DOI":"10.3389\/fimmu.2021.675535","article-title":"Inhibition of extracellular cathepsin D reduces hepatic lipid accumulation and leads to mild changes in inflammationin NASH mice","volume":"12","author":"Yadati","year":"2021","journal-title":"Front. Immunol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2947549","DOI":"10.1155\/2020\/2947549","article-title":"Liraglutide attenuates nonalcoholic fatty liver disease by modulating gut microbiota in rats administered a high-fat diet","volume":"18","author":"Zhang","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"B68","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s13578-021-00731-0","article-title":"Antioxidant supplements promote tumor formation and growth and confer drug resistance in hepatocellular carcinoma by reducing intracellular ROS and induction of TMBIM1","volume":"11","author":"Zhang","year":"2021","journal-title":"Cell Biosci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/hep.29889","article-title":"Ubiquitin-specific protease 4 is an endogenous negative regulator of metabolic dysfunctions in nonalcoholic fatty liver disease in mice","volume":"68","author":"Zhao","year":"2018","journal-title":"Hepatology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"155241","DOI":"10.1016\/j.metabol.2022.155241","article-title":"Higd1a facilitates exercise-mediated alleviation of fatty liver in diet-induced obese mice","volume":"134","author":"Zhu","year":"2022","journal-title":"Metabolism"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1081334\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T02:59:40Z","timestamp":1678935580000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1081334\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,16]]},"references-count":70,"alternative-id":["10.3389\/fphar.2023.1081334"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1081334","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,16]]},"article-number":"1081334"}}